NCT01020331View on ClinicalTrials.gov

Memantine Therapy in Amyotrophic Lateral Sclerosis

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

October 31, 2009

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Memantine

Trial Locations (1)

85018

Phoenix Neurological Associates, LTD, Phoenix

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Phoenix Neurological Associates, LTD

OTHER